February 18, 2016Open Access
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Key Points
Key points are not available for this paper at this time.
Abstract
Nct01177228, Nct00619489, Nct00783718, Nct00783692, Nct01224171, Nct00790933.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
Jean‐Frédéric Colombel
Semmelweis University
Bruce E. Sands
Statens Serum Institut
Paul Rutgeerts
University of Leeds
Journals
Gut
Actions
Institutions
University of California, San Diego
Mayo Clinic
Icahn School of Medicine at Mount Sinai
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...